Promise and challenges in drug discovery and development of hybrid anticancer drugs

By Gediya Lalji K   Njar Vincent CO  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 11, 2009-11 ,pp. : 1099-1111

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs

By  

Current Medicinal Chemistry, Vol. 17, Iss. 35, 2010-12 ,pp. : 4270-4290

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Nanocarriers for Anticancer Drugs Delivery

By  

Current Medicinal Chemistry, Vol. 23, Iss. 20, 2016-08 ,pp. : 2159-2187

Bentham Science Publishers

Access to resources Recommend Favorite

Geminin as A Molecular Target for the Development of New Anticancer Drugs

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-04 ,pp. : 461-462

Bentham Science Publishers

Access to resources Recommend Favorite

Development of distamycin-related DNA binding anticancer drugs

By Marchini Sergio   Broggini Massimo   Sessa Cristiana   D’Incalci Maurizio  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 9, 2001-09 ,pp. : 1703-1714

Informa Healthcare

Access to resources Recommend Favorite